Technology | Patient Monitors | May 16, 2018

Itamar Medical Launches SleePath for AFib Patients at Heart Rhythm 2018

e-Health Cardio Sleep Dashboard provides timely insights into patients’ sleep status and compliance with sleep apnea therapy specially design for cardiologists needs

Itamar Medical Launches SleePath for AFib Patients at Heart Rhythm 2018

May 16, 2018 — Itamar Medical Ltd. announced the launch of SleePath, the first integrated e-health sleep apnea care pathway monitoring system to monitor atrial fibrillation (AF) patients’ sleep apnea management status and compliance with continuous positive airway pressure (CPAP) devices on demand.

Effective management of sleep apnea is essential for improving outcomes in patients with AF, a type of irregular heartbeat that affects 6 million individuals in the United States. SleePath was unveiled at Heart Rhythm 2018, the annual meeting of the Heart Rhythm Society, May 9-12 in Boston.

Sleep apnea occurs in roughly 50 percent of patients with AF; it is found in a higher proportion of AF patients scheduled for catheter ablation, a minimally invasive procedure commonly used to treat AF, which eliminates the cells that give rise to irregular heartbeat. In AF patients with sleep apnea, catheter ablation is most effective when used in conjunction with adherence to a CPAP regimen.

“Effective management of sleep apnea is now believed to be critical for controlling atrial fibrillation post-ablation. The ability for us, the electrophysiologists, to assess patients’ sleep apnea status and their adherence to CPAP on demand and correlating it to the AF manifestations is a big help,” said Elad Anter, M.D., of Beth Israel Deaconess in Boston. “The information that SleePath provides is important for achieving optimal outcomes following catheter ablation. Knowing that a patient isn’t using their CPAP as prescribed is an important first step in opening a dialog with the sleep experts that can identify obstacles and help improve adherence.”

Utilizing data from the Philips Respironics CPAP machines, SleePath includes a Cardio Sleep Dashboard that allows physicians to track multiple aspects of a patient’s sleep apnea status anytime and anyplace. The system monitors care pathway progress, diagnosis status and results, CPAP compliance, the number of days and hours on CPAP, and residual sleep apnea. Data are presented in a user-friendly visual format that makes it easy to see progress or deviation toward specific treatment goals and changes in metrics over time.

For more information: www.itamar-medical.com

Related Content

News | Atrial Fibrillation

November 17, 2021 — People with atrial fibrillation (AFib) who underwent individualized testing to discover triggers for ...

Home November 17, 2021
Home
News | Atrial Fibrillation

September 28, 2021 — Image-guided fibrosis ablation in addition to pulmonary vein isolation (PVI) does not improve ...

Home September 28, 2021
Home
News | Atrial Fibrillation

September 13, 2021 — Ablation plus cardiac resynchronization therapy (CRT) is superior to pharmacological rate control ...

Home September 13, 2021
Home
News | Atrial Fibrillation

September 8, 2021 — Continuous heart rhythm monitoring – with anticoagulation if atrial fibrillation is detected – does ...

Home September 08, 2021
Home
News | Atrial Fibrillation

August 9, 2021 — Adagio Medical Inc., a provider of catheter ablation technologies for atrial fibrillation (AF) and ...

Home August 09, 2021
Home
News | Atrial Fibrillation

June 23, 2021 — The U.S. Food and Drug Administration (FDA) expanded approval for Medtronic's Arctic Front Family of ...

Home June 23, 2021
Home
News | Atrial Fibrillation

April 19, 2021 — National Heart, Lung, and Blood Institute (NHLBI) has awarded a grant for $462,689 to Rhythm ...

Home April 19, 2021
Home
News | Atrial Fibrillation

March 3, 2021 — Farapulse Inc. announced the first patients were treated in the ADVENT Trial, a U.S. Food and Drug ...

Home March 03, 2021
Home
News | Atrial Fibrillation

January 29, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Medtronic's DiamondTemp Ablation (DTA) system ...

Home January 29, 2021
Home
Feature | Atrial Fibrillation | By John D. Day, M.D., T. Jared Bunch, M.D., and Matthew D. LaPlante

In our most challenging and distressing days, it is nice to think about a post-COVID-19 world. But while this pandemic ...

Home January 27, 2021
Home
Subscribe Now